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Abstract A new form of circuitry for gene regulation has
been identified in which RNAs can crosstalk by competing
for shared microRNAs (miRNAs). Such competing en-
dogenous RNAs (ceRNAs) form a network via shared
miRNA response elements (MREs) to antagonize miRNA
function. We previously reported natural antisense RNA
(AS) as an important modulator of interferon-a1 (IFN-a1)
mRNA levels by promoting IFN-a1 mRNA stability. We
show that IFN-a1 AS forms a ceRNA network with
specific IFN-a AS (IFN-a7/-a8/-a10/-a14) and mRNA
(IFN-a8/-a10/-a14/-a17) subtypes from the IFN-a gene
(IFNA) family to antagonize miRNA-1270 (miR-1270),
thereby modulating IFN-a1 mRNA levels. Bioinformatic
analysis demonstrated that IFN-a1 AS harbors multiple
miR-1270 MREs (MRE-1270s), whose presence was sub-
stantiated by miR-1270 overexpression and transfection of
antimiR-1270. The antimiR-1270, complementary to the
miR-1270 seed region, revealed that IFN-a1 AS likely
shares the MRE-1270 with IFN-a1 mRNA and specific
IFN-a AS and mRNA subtypes. Subsequent bioinformatic
analysis for MRE-1270s showed that IFN-a1 AS and other
RNA subtypes shared the 6-mer MRE-1270 site. Further
MRE-mapping demonstrated that the total number of
MRE-1270s in IFN-a1 AS accounted for approximately
30 % of the miR-1270 population. AntimiR-1270 trans-
fection also caused specific de-repression of five cellular
mRNAs, including that of CAPRIN1. These results suggest
that IFN-a1 AS, together with specific IFN-a AS and
mRNA subtypes, as well as the five cellular mRNAs,
participate as competing molecules in the ceRNA network
against miR-1270. This coordinated regulatory architecture
suggests a vital function for the innate immune system in
maintaining precise physiological type I IFN levels via
post-transcriptional regulatory mechanisms.
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R Revertant
DS Downstream fragment of IFNA1
30 UTR
DSR Antisense fragment downstream
of IFNA1 30 UTR
PCR Polymerase chain reaction








CAPRIN1 Cell cycle-associated protein 1,
transcript variant 1
CTSE Cathepsin E (CTSE) transcript
variant 1
GLI2 GLI family zinc finger 2
KRT40 Keratin 40
LYZ Lysozyme
MARCH5 Membrane-associated ring finger
(C3HC4) 5
OTUD3 OTU deubiquitinase 3
RASAL2 RAS protein activator-like 2,
transcript variant 2
TC2N Tandem C2 domains, nuclear,
transcript variant 1
PI3K Phosphatidylinositol-3 kinase
Mnk Mitogen-activated protein kinase-
integrating kinase 1
Introduction
Until recently, the main role of RNA was considered to be
that of an intermediary between the DNA code and its final
incarnation as protein [1]. However, this hardly captures
the complex interplay between the biomolecular trio of life,
as has been made clear by the recent advances made by
genome studies; the Encyclopedia of DNA Elements
(ENCODE) project reported that three-quarters of the hu-
man genome was capable of being transcribed [2], of which
merely 2.94 % was transcribed into protein-coding mRNAs
[3]. This indicates that contrary to central dogma [1], non-
coding RNAs (ncRNAs) represent most of the human
transcriptome.
The importance of this non-coding transcriptome has
become increasingly clear in recent years. Comparative
genomic analysis has demonstrated a significant difference
in genome utilization among species; e.g., the protein-
coding genome constitutes almost the entire genome of
unicellular yeast, but only 2 % of the mammalian genome
[4]. Furthermore, the non-coding transcriptome is often
dysregulated in cancer [5]. These observations suggest that
the transcriptome is of crucial importance in the greater
complexity of higher eukaryotes and in mechanisms of
pathogenesis [6, 7]. Assigning function to non-coding se-
quence will, therefore, undoubtedly lead to important
insight about basic physiology and disease progression [8].
ncRNAs comprise multiple classes of RNA transcripts
that regulate transcription, stability or translation of pro-
tein-coding genes in the mammalian genome [9]. Natural
antisense transcripts (NATs) form such a class and are
transcribed from the opposite strand of protein-coding or
non-protein-coding (sense) genes. The GENCODE v7
catalog contains 9640 long non-coding RNA (lncRNA)
loci, representing 15,512 transcripts, of which 3214 are
antisense loci [10].
Recently we have identified and characterized in detail
one such sense–antisense pair, interferon-a1 (IFN-a1)
mRNA and its antisense partner IFN-a1 AS. We demon-
strated a critical role of this non-coding NAT in the post-
transcriptional regulation of the IFN-a1 gene (IFNA1), and
subsequently, IFN-a1 protein production [11]. A *4 kb,
spliced IFN-a1 AS targets a single-stranded region, called
the bulged-stem loop (BSL) within a conserved secondary
structure element formed in the IFN-a1 mRNA-coding
region, but not in the usual 30-untranslated region (30-UTR)
[12]. Upon recognition of the BSL region, the cytoplasmic
sense–antisense interaction between the complementary
transcripts results in stabilization of the IFN-a1 mRNA
[11]. Here, we report evidence that IFN-a1 AS forms a
competing endogenous RNA (ceRNA) network with
specific IFN-a AS RNA and mRNA subtypes from the
IFNA multigene family, as well as with several other cel-
lular transcripts, to antagonize miRNA-1270-induced
destabilization of IFN-a1 mRNA.
The mechanisms by which NATs regulate gene ex-
pression are largely unknown. Cytoplasmic sense–
antisense duplex formation can alter sense mRNA stability
and translation efficiency. The region of overlap between
mRNAs and NATs might affect mRNA stability to reduce
mRNA decay (this decay is via endo- or exonucleolytic
degradation by various RNases; reviewed by Nishizawa
et al. [13, 14]). Indeed, we have previously demonstrated
that NATs for the gene encoding inducible nitric oxide
synthase (iNOS), an important gene in inflammatory dis-
eases, increase the stability of iNOS mRNA [15].
Enhancement of iNOS mRNA stability was mediated
through interactions of the NAT molecules with the AU-
rich element (ARE)-binding human antigen R (HuR) pro-
tein. HuR could, in turn, suppress RNA degradation by
inhibiting deadenylation or exonucleases [15]. In contrast,
alterations in the secondary structure of hypoxia-induced
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factor 1a (HIF1A) mRNA by an NAT could reduce the
stability of the mRNA by exposing the ARE and making
the RNA prone to degradation [16].
We recently demonstrated that IFN-a1 AS was involved
in determining post-transcriptional IFNA1 mRNA levels
[11]. Overexpression of IFN-a1 AS in pLKO-null [17] -
virus-transduced Namalwa cells consistently raised IFN-a1
mRNA levels after Sendai virus (SeV) infection. pLKO-
miR-1270 virus-transduced cells had significantly reduced
IFN-a1 mRNA levels, whereas subsequent overexpression
of IFN-a1 AS returned the mRNA to basal levels. These
results thus suggest that IFN-a1 AS and miR-1270 may
compete for binding to IFN-a1 mRNA [11].
According to recent literature ([8] and references
therein), this proposed miRNA masking effect would apply
only to a specific set of RNA competitors, the abundance of
which and of corresponding targets, should fall within a
narrow, equimolar range, as the expression of competitor
RNAs would have little impact on the regulation of highly
abundant miRNAs. Since the relative expression levels of
IFN-a1 AS were 4–6 % of IFN-a1 mRNA levels [11], we
decided to investigate whether the AS itself harbors bind-
ing sites for miR-1270, which targets IFN-a1 mRNA.
These binding sites are termed miR-1270 response ele-
ments or MRE-1270s [18] and act as a target RNA decoy
or a ceRNA [19–21] against miR-1270.
Furthermore, the IFNA multigene family consists of 13
functional subtypes that show high sequence similarity to
IFNA1 (see below). Since all the IFN-a mRNA subtypes
are expressed in Namalwa cells after SeV infection [22],
we investigated whether IFN-a1 AS may form an antimiR-
1270 ceRNA network [8] with the other IFN-a mRNA
subtypes and their antisense partners. We also investigated
whether other cellular mRNAs that share MRE-1270s
participate in the network.
Materials and methods
Cell culture and virus propagation
Human Namalwa B cells (B lymphocytes from Burkitt’s
lymphoma; ATCC CRL-1432) were maintained as previ-
ously described [11]. SeV was propagated as described
[11] using embryonated chicken eggs. The hemagglutina-
tion titer of SeV was determined by serial titration of virus
stocks in eggs.
Plasmid construction
For the construction of plasmids for mapping MRE-1270s
on the IFN-a1 mRNA and IFN-a1 AS RNA, phuIFN-a1
AS/exon 1.1, phuIFN-a1, phuIFN-a1/SL2Revertant (R),
/BSLRevertant (/BSLR), and /50-UTRRevertant (/50-
UTRR) expression plasmids [11] were digested with Hin-
dIII/XbaI and then blunt end ligated into the blunt-ended
XbaI site of the pEF-Luc reporter plasmid [15], to generate
pEF-Luc-IFN-a1-AS/exon1.1, -mRNARevertant (-mRNAR),
-SL2 and -SL2R, -BSL and BSLR, and -50-UTRR,
respectively. The orientation of the inserts was confirmed
by DNA sequencing (data not shown). For the con-
struction of pEF-Luc-IFN-a1-SL2/DBSL, inverse
polymerase chain reaction (PCR) was employed to gener-
ate the internal deletion mutant using the primer pair of
DBSL-invF1 and DBSL-invR1. The inverse PCR-based
mutagenesis was performed using the KOD-plus mutage-
nesis kit (TOYOBO, Osaka, Japan), according to the
manufacturer’s instructions. For the construction of pEF-
Luc-IFN-a1-AS/exon 0.1, -30-UTRR-DSRevertant (-30-
UTRR-DSR), -(SL2-stop codon)Revertant (R), and -(ATG-
SL1)Revertant (R), the human IFNA1 AS nucleotide se-
quence, encoding the 0.1 kb exon, the IFNA1-30-
untranslated region (30-UTR) as well as the downstream
fragment (DS) of the 30-UTR (30-UTR-DS), (SL2-stop
codon)R and (ATG-SL1)R were amplified by PCR using
Namalwa cell genomic DNA as template [11]. The gene-
specific primer pairs were: exon 0.1F and exon 0.1R to
generate pEF-Luc-IFN-a1-AS/exon 0.1; 30 UTR-F and
DSR to generate pEF-Luc-IFN-a1-30UTRR-DSR; SL2-stop
F and SL2-stop R to generate pEF-Luc-IFN-a1-(SL2-stop
codon)R; ATG-SL1 F and ATG-SL1 R to generate pEF-
Luc-IFN-a1-(ATG-SL1)R. To construct pEF-Luc-
CAPRIN1 30-UTR, total RNA from Namalwa cells was
reverse transcribed with the CARIN1 R1 primer and cDNA
was amplified by PCR using the CAPRIN1 F and R primer
pair. The gene-specific primers used are listed in Supple-
mentary Table 1. All the amplicons were digested with
XbaI and inserted into the XbaI site of pEF-Luc. The ori-
entation of the inserts was confirmed by DNA sequencing
(data not shown). Human chromosome 9 fragments con-
taining IFNA7, IFNA8, IFNA10 or IFNA14 were amplified
by PCR using the gene-specific primer pairs listed in
Supplementary Table 1 and Namalwa cell genomic DNA
as template. Each amplicon was then digested with HindIII/
XbaI and cloned into the HindIII/XbaI sites of pSI [11] to
generate phuIFN-a7, -a8, -a10 and -a14 expression vec-
tors. For phuIFN-a17, see Kimura et al. [11].
Oligonucleotides
Unconjugated locked nucleic acid (LNA)-modified an-
timiR-1270 oligonucleotides were synthesized with a
complete phosphorothioate backbone (Gene-Design,
Osaka, Japan). The sequence of antimiR-1270 was com-
plementary to the seed region of the mature miR-1270
(nucleotides 2–9). The LNA mismatch control was
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designed according to the miR-1270 seed region sequence.
These sequences and names are listed in Supplementary
Table 1.
Transfection, virus infection and isolation of total
cellular RNA
Namalwa cells and the recombinant pLKO-miR-1270
lentivirus-transduced Namalwa cells [11] were subjected
to magnet-assisted transfection, as described previously
[11]. The transfection efficiencies were optimized when
3 lg of plasmid DNAs per 9.5 cm2 well was used at a 1:1
ratio with the MATraTM (IBA GmbH, Go¨ttingen, Ger-
many) transfection reagent for complex formation. At
either 6 or 20 h after transfection, the transfected Na-
malwa cells were then washed and infected with 50
hemagglutination units of SeV/106 cells for 60 min. The
transfected and infected Namalwa cells, and the trans-
fected pLKO-miR-1270 lentivirus-transduced Namalwa
cells were further incubated at 37 C for 24 and 48 h,
respectively. Total cellular RNA was then isolated from
cells, as described previously [11]. Namalwa cells were
transfected as described above with both the LNA nu-
cleotides (333 nM final concentration) and pEF-Luc
(400 ng) and incubated for 6 h. The cells were then
washed and infected with SeV. After 24 h, total cellular
RNA was isolated as described above.
Strand-specific reverse-transcription quantitative
polymerase chain reaction (RT-qPCR)
RT-qPCR was performed essentially as described previ-
ously [11]. Details of the primer sequences and locations
within the corresponding genes are shown in Supplemen-
tary Table 1. The results are based on cycle threshold (Ct)
values. Differences between the Ct values for experimental
and reference (Human 18S rRNA) genes were calculated as
DDCt [11]. Alternatively, using the samples shown in
Fig. 3c, the copy numbers of IFN-a1 AS or mRNA were
determined [11] to calculate the number of MRE-1270s. To
determine miR-1270 copy number, total cellular RNA that
was highly enriched for small RNAs was prepared from the
samples used to produce the data in Fig. 3c using a mir-
VanaTM miRNA isolation kit (Ambion Inc., Austin, TX,
USA) according to the manufacturer’s instructions. The
total cellular RNA was then reverse transcribed with
specific primers using the TaqMan MicroRNA Reverse
Transcription Kit (Applied Biosystems, Carlsbad, CA,
USA), and real-time PCR was conducted using the Taq-
Man MicroRNA Assay Kit for either hsa-miR-1270 or U6
snRNA (Applied Biosystems) according to the manufac-
turer’s instructions. U6 snRNA was employed as an
internal standard to normalize the total cellular RNA
samples. Tenfold dilutions of a known concentration of a
synthetic miR-1270 standard: 50-CUGGAGUAUGGAA-
GAGCUGUGU-30 (Gene-Design) were assayed in the
same run using the TaqMan MicroRNA Assay Kit. The
regression lines from each dilution curve were used to
determine the miR-1270 copy numbers in each sample.
Assessment of the cross-reactivity of mRNA/AS RNA
PCR primer pairs for an IFNA subtype against the other
family subtypes and of the sequence homology
of IFNA1 against other IFNA family genes
Sequence alignment analyses of mRNA/AS PCR primer
pairs for an individual IFNA family subtype and for IFNA1
were performed against the other genes in the family using
a function of GENETYX-MAC software (Ver. 15.0.0)
(Genetyx Corporation, Tokyo, Japan).
Statistical analysis and informatics
Results in the figures are representative of at least three
independent experiments with multiple samples (n: 4–6)
generating similar findings. Differences presented in the
figures were analyzed using Student’s t test.
Accession numbers
Gene accession numbers deposited in DDBJ/EMBL/
GenBank were as follows: AB578886 (human IFNA1),
AB578885 (human IFNA1 AS). The sequence numbering
presented in this report is based on the following DDBJ/
EMBL/GenBank human sequences: IFNA2; NM_000605.3,
IFNA4; NM_021068.2, IFNA5; NM_002169.2, IFNA6;
NM_021002.2, IFNA7; NM_021057.2, IFNA8; NM_002
170.3, IFNA10; NM_002171.2, IFNA13; NM_006900.3,
IFNA14; NM_002172.2, IFNA16; NM_002173.2, IFNA17;
NM_021268.2 and IFNA21; NM_002175.2, cell cycle-as-
sociated protein 1 (CAPRIN1), transcript variant 1, mRNA;
NM_005898.4, Cathepsin E (CTSE), transcript variant 1,
mRNA; NM_001910.3, GLI family zinc finger 2 (GLI2),
mRNA; NM_005270.4, Keratin 40 (KRT40), mRNA;
NM_182497.3, Lysozyme (LYZ), mRNA; NM_000239.2,
Membrane-associated ring finger (C3HC4) 5 (MARCH5),
mRNA; NM_017824.4, OTU deubiquitinase 3 (OTUD3),
mRNA; NM_015207.1, RAS protein activator-like 2
(RASAL2), transcript variant 2, mRNA; NM_170692.2 and
Tandem C2 domains, nuclear (TC2N), transcript variant 1,
mRNA; NM_152332. The miRNA precursor genes em-
ployed in this study were hsa-miR-1270, -miR-1287, and
-miR-483 (DDBJ/EMBL/GenBank sequences: MI00064
07, MI0006349 and MI0002467, respectively).
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Results
Validation of the miR-1270 binding site in the bulged-
stem loop (BSL) region within the conserved secondary
structure (CSS) of IFN-a1 mRNA by luciferase
constructs
We recently reported that IFN-a1 AS prevented miRNA-
induced destabilization of the IFN-a1mRNAbymasking the
predictedmiR-1270 binding site, thereby increasing stability
of the mRNA [11]. To validate the predicted miR-1270
binding site in the IFN-a1 mRNA (Fig. 1a; reproduced from
[11] with permission), we engineered the BSL-containing
IFNA1 stem loop (SL)2 fragment downstream of a luciferase
reporter gene.We found that insertion of SL2 is sufficient for
significant reduction of luciferase reporter activity in pLKO-
miR-1270 virus-transduced cells (Fig. 1b, SL2; p\ 0.01).
Deletion of the BSL from the SL2 fragment abolished the
reduction of luciferase reporter activity, whereas replacing
this fragment with the BSL alone resulted in significant re-
duction of luciferase activity (Fig. 1b, SL2/DBSL, and BSL;
p\ 0.01, respectively). These results indicate that the pre-
dicted miR-1270 binding site is indeed present in the BSL
region, suggesting the possibility of in vivo interaction be-
tweenmiR-1270 and its cognate binding site, orMRE,within
the CSS SL2 of the IFN-a1 mRNA.
Covering the MRE-1270 by IFN-a1 AS might eliminate
miRNA-induced IFN-a1 mRNA decay. It follows that
cytoplasmic sense–antisense RNA duplex formation can
potentially inhibit the interactions between miR-1270 and
IFN-a1 mRNA. This can explain, at least in part, the en-
hancement of IFN-a1 mRNA stability by IFN-a1 AS [11].
According to recent studies ([8] and references therein),
this proposed miRNA masking effect would, however, only
apply to a set of RNA competitors, the abundance of which
and of corresponding targets fall within a narrow,
equimolar range, as the expression of competitor RNAs
would have little impact on regulation of highly abundant
miRNAs. Furthermore, it has become clear that non-coding
transcripts sharing MREs with coding transcripts can be
similarly targeted, sequestering miRNAs to prevent them
from acting on the protein-coding mRNAs, resulting in a
complex network of ceRNAs to indirectly modulate each
other’s abundance through the shared MREs ([18] and
references therein).
Since the relative expression levels of IFN-a1 AS were
only 4–6 % of IFN-a1 mRNA levels [11], we investigated
the possibility that IFN-a1 AS might also function through
its ability to act as a ceRNA in addition to, or as an al-
ternative way of competing with miR-1270 for IFN-a1
mRNA [20]. Such activity would in turn affect the distri-
bution of miR-1270 on its targets, thereby modulating the
de-repression of miRNA targets through the MREs [19,
21], resulting, in this case, in increased IFN-a1 mRNA
levels.
Validation of miR-1270 MREs in the IFN-a1 AS
To validate the presence of miR-1270 MREs in the IFN-a1
AS, we overexpressed miR-1270, -1287, or -483 in SeV-
Fig. 1 Validation of the miR-1270 response element (MRE-1270) in
the BSL region of IFN-a1 mRNA. a The schematic shows the
predicted binding sites for miR-1270 (nt 333–308), miR-1287 (nt
324–303), and miR-483 (nt 226–205) (all in black bold lines) and
their relation to the BSL region (IFNA1 nt 322–352; red bold line) in
the conserved secondary structure of IFN-a1 mRNA. Figure repro-
duced with modification from Kimura et al. [11] with permission. b A
series of pEF-Luc (luciferase) reporters harboring SL2, SL2/DBSL or
BSL of IFN-a1 mRNA were transfected into the recombinant pLKO-
miR-1270 lentivirus-transduced Namalwa cells. Luciferase assays
were performed 48 h after transfection as described previously [51].
The luciferase activities were normalized to the enzymatic activity
determined in parental pEF-Luc reporter-transfected cells (Cont) and
are presented as the ‘‘relative luciferase activity’’, which indicates
percent reporter activity relative to that of Cont as 100 %. Values of a
representative experiment of three independent transfection ex-
periments are presented as the mean ± SEM of four or five
samples. **p\ 0.01. The transfection efficiencies of each reporter
construct shown were normalized to Renilla luciferase activity, an
internal transfection standard
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infected Namalwa cells. miR-1287 and -483 target the
double-stranded ‘‘stem’’ regions adjacent to the sin-
gle-stranded BSL region (Fig. 1a) and were previously
employed as negative controls in an IFN-a1 AS/miR-1270
competition assay for mRNA binding [11]. Exogenous and
endogenous expression of these miRNAs was verified by
quantification of each miRNA in transfected and control
Namalwa cells (data not shown) (see [11] for information
on primers in this assay). Similar to the effect on IFN-a1
mRNA levels [11], overexpression of miR-1270 sig-
nificantly reduced IFN-a1 AS levels in the SeV-infected
Namalwa cells, whereas miR-1287 had no such effect
(Fig. 2a, miR-1270 O/E, p\ 0.01; miR-1287 O/E). How-
ever, unlike IFN-a1 mRNA, overexpression of miR-483
significantly reduced IFN-a1 AS levels (Fig. 2a, miR-483
O/E, p\ 0.01). While miR-483 reduced AS levels by
33 %, overexpression of miR-1270 caused a 75 % reduc-
tion in AS levels 24 h after viral infection. In our previous
report [11], overexpression of miR-483 failed to reduce
IFN-a1 mRNA levels; therefore, the results shown in
Figs. 1 and 2a indicate that IFN-a1 AS and mRNA share
MRE-1270.
We then assessed the effect of endogenous miR-1270 on
IFN-a1 AS/mRNA expression levels by employing an
antimiR approach to inhibit endogenous miR-1270 [23].
For this knockdown strategy, we designed an 8-mer an-
timiR-1270, a fully LNA-modified phosphorothioate
oligonucleotide complementary to the seed region of miR-
1270 [23]. We tested its effects on IFN-a1 AS and mRNA
expression in SeV-infected Namalwa cells. Transfection of
the antimiR-1270 resulted in potent antagonism of miR-
1270, as shown by specific and significant de-repression of
both IFN-a1 AS and mRNA expression (Fig. 2b, c) with a
maximal effect observed at 333 nM (antimiR-1270 titra-
tion data not shown). Silencing endogenous miR-1270
increased IFN-a1 AS and mRNA levels by 360 and 140 %,
respectively, compared to an LNA mismatch control.
Overexpression of miR-1270 and inhibition of endogenous
miR-1270 function by the antimiR-1270 thus indicate that
compared to IFN-a1 mRNA, IFN-a1 AS is more suscep-
tible to miR-1270-dependent degradation through the
MRE, thereby potentially preventing miR-1270 from act-
ing on IFN-a1 mRNA.
Fig. 2 Validation of the effect of miR-1270 on IFN-a1 AS. a Effects
of overexpressed miR-1270, miR-1287 and miR-483 on IFN-a1 AS
expression were examined in SeV-infected Namalwa cells. The cells
were harvested for the subsequent RT-qPCR analyses as described in
the Materials and methods section. IFN-a1 AS levels were normal-
ized to 18S rRNA and are presented as ‘‘relative IFN-a1 AS
expression’’, which indicates the fold change of the AS level relative
to that of the control vector, [pEGFP-miR-null vector-transfected
cells (Cont)] at 24 h after SeV infection. Values are presented as
described in the legend to Fig. 1 (**p\ 0.01). b, c Effects of
inhibition of endogenous miR-1270 function on IFN-a1 AS/mRNA
expression levels. LNA-modified antimiR-1270 was transfected into
Namalwa cells, which were then infected with SeV and harvested for
RT-qPCR analyses of relative IFN-a1 AS (b) and mRNA (c) expres-
sion as described above. The relative expressions indicate the fold
change of AS/mRNA levels relative to those obtained in the LNA
mismatch control-transfected, SeV-infected cells. (-) mock transfec-
tion. *p\ 0.05, **p\ 0.01
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Characterization of MRE-1270 sites in the IFN-a1 AS
RNA
The relative abundance of both ceRNAs and miRNAs, their
stoichiometry and the number of shared MREs are crucial
determinants of ceRNA cross-regulation ([8] and references
therein). We, therefore, searched for MRE-1270 motifs in
the entire IFN-a1 AS RNA/exon 0.1 and 1.1 sequence.




multimitar.htm; [26]) predicted the presence of five highly
conserved MRE-1270 sites in the IFN-a1 AS RNA/exons
0.1 and 1.1 (Fig. 3a and listed in Supplementary Table 4).
These algorithms predict MRE-1270 sites based on se-
quence complementarity and free energy of the RNA
duplex. We accepted free energy values that were less than
-10 kcal/mol, as suggested by Zhang and Verbeek [27].
To investigate whether these motifs can actually act as
MRE-1270s, the IFN-a1 AS segments that harbor these
predicted MRE-1270s (Fig. 3b) were inserted downstream
of the luciferase reporter gene and their effects tested on
luciferase reporter activity in pLKO-miR-1270 virus-
transduced cells. For this reporter assay, we included a
positive control, which enabled us to quantitatively assess
the relationship between the miRNA and its MREs and to
analyze the effect of this relationship on the luciferase
reporter gene expression.
IFN-a1 mRNA is the only target molecule for miR-1270
that has been reported [11]; therefore, we searched for
positive control candidate genes that harbor potential MRE-
1270s using bioinformatics analysis with the following al-
gorithms: miRDB, http://mirdb.org/miRDB/index.html
[28]; miRWalk, http://www.umm.uni-heidelberg.de/apps/
zmf/mirwalk/index.html [29]; RNA22, https://cm.jeffer
son.edu/rna22v2.0-homo_sapiens/GetInputs.jsp [30]; Tar-
getscan, http://www.targetscan.org/vert_61/ [31] and
TargetSpy, http://www.targetspy.org/ [32]. Based on this
analysis, nine genes were predicted, of which two,CTSE and
GLI2, were not expressed in Namalwa cells (Supplementary
Fig. 1a). Transfection of Namalwa cells with antimiR-1270
resulted in specific and significant de-repression of five out of
the remaining seven mRNAs. Compared to the LNA mis-
match control, silencing endogenous miR-1270 increased
the expression levels of these mRNAs by between 1.2- and
1.8-fold, whereas the levels of IFN-a1 ASwere increased by
4.2-fold (Supplementary Fig. 1a). Of these five mRNAs, we
selected the cell cycle-associated protein 1 (CAPRIN1),
transcript variant 1, mRNA, which showed the greatest
levels of de-repression, as the positive control for the reporter
assay. We inserted a segment of the CAPRIN1 30-UTR,
which was predicted to hold one MRE-1270, downstream of
the Luc reporter gene and titrated the CAPRIN1 reporter to
optimize the reduction of luciferase activities in the pLKO-
miR-1270-transduced Namalwa cells (Supplementary
Fig. 1b). A linear correlation was observed between lu-
ciferase activity and luciferase reporter plasmid doses
ranging from0.7 to 2.2 lg; therefore, we employed 1.4 lg of
each of the reporter plasmids, which caused the most sig-
nificant reduction in activity, for the reporter assay shown in
Fig. 3b.
The luciferase reporter assay revealed that insertion of
IFN-a1 AS RNA segments that were predicted to hold one
MRE-1270 each (see Supplementary Table 4), i.e., (ATG-
SL1)R, SL2R, (SL2-stop)R and 30-UTRR-DSR regions of
IFN-a1 AS/exon 1.1, as well as AS/exon 0.1, reduced lu-
ciferase activity to a level comparable with that of the
CAPRIN1 positive control. In addition, insertion of both
IFNA1 AS/exon 1.1 and mRNAR caused further significant
reduction in reporter signal when compared with the
positive control, suggesting cumulative effects of miR-
1270 on transcripts with several MREs (Fig. 3b). These
results thus validate the presence of predicted MRE-1270s
in the (ATG-SL1)R, SL2R, (SL2-stop)R and 30-UTRR-
DSR regions of IFN-a1 AS/exon 1.1 as well as in AS/exon
0.1.
We then measured the copy numbers of IFN-a1 AS, the
mRNA and miR-1270 in SeV-infected Namalwa cells to
calculate the number of MRE-1270s. In cells, the numbers
of IFN-a1 AS/mRNA and miR-1270 molecules were
1558 ± 82, 19272 ± 2728 and 100100 ± 9696 per lg of
total cellular RNA extracted at 24 h after viral infection,
respectively (Fig. 3c). Since five IFN-a1 AS RNA seg-
ments containing five MRE-1270s were mapped to exons
0.1 and 1.1, and LNA-antimiR-1270 treatment resulted in a
3.6-fold increase of endogenous IFN-a1 AS expression
levels, the number of MRE-1270s in the entire IFN-a1 AS
could be no less than 1558 9 5 9 3.6 = 28044, which
accounts for 28 % of miR-1270.
Silencing miR-1270 by LNA-antimiR-1270 raised
the AS/mRNA expression levels of specific subtypes
of the IFNA multigene family
ceRNA crosstalk is optimal when the abundance of miR-
1270 and ceRNA transcripts is nearly equimolar [33, 34];
therefore, we examined the effects of endogenous miR-
1270 knockdown on the expression levels of mRNAs and
their antisense partners from thirteen subtypes of the IFNA
family. Strand-specific RT-PCR was employed to identify
IFN-a mRNA subtypes and their AS RNAs, as successfully
used previously to differentiate and identify IFN-a1
mRNAs and AS RNAs [11].
IFNA1 has high sequence similarity with the other IFNA
subtypes (Supplementary Table 2); therefore, prior to
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conducting the strand-specific RT-PCR analysis of each
IFN-a AS/mRNA, a homology search of the PCR primer
pairs used to detect any specific IFN-a AS and mRNA
subtype was performed against other subtypes of the IFNA
family (Supplementary Table 3). The presence of con-
taminating IFN-a cDNA signals was subsequently
examined using plasmids that contain cDNAs, encoding
genes with high, medium or low homology to the specific
IFNA gene (Supplementary Fig. 2) [11].
As previously reported [11], each plasmid was digested
at either the 50 or 30 end and used as a template to identify
contaminating antisense or sense RNA signals. The amount
of any specific IFNA plasmid was then titrated to produce
sense or antisense cDNA signals close to those obtained
from IFN-a mRNA and AS of the corresponding subtype,
respectively. This amount was then applied to
amplifications using plasmids with high, medium or low
homology. As shown in Supplementary Fig. 2, the primer
pairs designed to amplify AS RNAs of IFN-a7, -a8, -a10
and -a14, as well as mRNAs of -a8, -a10, -a14 and -a17
did not cross react with any of the three antisense or sense
cDNA mimics examined (the cross amplification assay was
not performed against those IFNA family subtypes for
which the antimiR-1270 treatment did not alter the RNA
expression levels; Fig. 4a, b).
The strand- and IFNA family member-specific RT-
qPCR, using the same samples used for the analysis shown
in Fig. 2b, c, revealed that while transfection of the LNA
oligodeoxynucleotides complementary to nucleotides 2–9
of mature miR-1270 resulted in specific de-repression of
miR-1270 targets, IFN-a1 AS/mRNA (Fig. 2b, c), the
miR-1270 antagonism also caused a significant increase in
Fig. 3 Characterization of MRE-1270s on IFN-a1 AS. a Location of
predicted miR-1270 binding sites on IFN-a1 AS/exons 0.1 and 1.1.
Bioinformatic analysis of miR-1270 binding sequences on IFN-a1
AS/exons 0.1 and 1.1 revealed the presence of five highly conserved
predicted MRE-1270s (closed triangles). b Confirmation of IFN-a1
AS segments harboring the predicted MRE-1270s. A series of pEF-
Luc reporters, into which the following IFN-a1 AS segments were
inserted; IFN-a1 AS/exon 1.1, mRNA-revertant (mRNAR), 50-UTRR,
(ATG-SL1)R, SL2R, BSLR, (SL2-stop)R, 30-UTRR-DSR, or IFN-a1
AS/exon 0.1 were transfected into pLKO-miR-1270-transduced
Namalwa cells. pEF-Luc-CAPRIN1 30-UTR, which harbors one
MRE-1270, was included as a positive control for the assay. The
luciferase activities were normalized and are presented as described in
the legend to Fig. 1. The transfection efficiencies of each reporter
were normalized to Renilla luciferase activity, an internal transfection
standard. *p\ 0.05, **p\ 0.01. Closed triangles are as described in
the legend to a. c Quantification of copy numbers of IFN-a1 AS/
mRNA and miR-1270. Namalwa cells were infected with SeV and
harvested for RT-qPCR analysis at 24 h after infection. Copy
numbers of IFN-a1 AS/mRNA and miR-1270 were determined from
the regression lines from the sets of standards as described in the
‘‘Materials and methods’’ section. The results are presented as the
‘‘Number of transcripts or miR-1270/lg of total cellular RNA’’
±SEM of four or five samples. High levels of sequence homology
between IFNA1 and IFNA13 (99.8 % in the coding region) did not
allow distinction between these genes [11]. The expression levels of
IFN-a1 mRNA and AS RNA presented in this study thus represent the
total amounts of both IFN-a1 and -a13 mRNA/AS RNA
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AS/mRNA expression levels for specific subtypes of the
IFNA family.
As shown in Fig. 4a, b, these subtypes were IFN-a7,
-a8, -a10 and -a14 AS RNAs as well as IFN-a8, -a10, -a14
and -a17 mRNAs. The increase in AS expression levels
ranged from 176 % for IFN-a7 to 430 % for IFN-a10,
relative to the mismatch control, whereas mRNA increases
were from 170 % for IFN-a17 to 270 % for IFN-a10
relative to the mismatch control. The antimiR-1270 treat-
ment raised the IFN-a1 AS levels by 3.6-fold (Fig. 2b),
whose MRE-1270s accounted for approximately 30 % of
miR-1270s. Furthermore, bioinformatic analysis using the
tools employed for Fig. 3a revealed that the de-repressed
IFN-a AS RNA/mRNA subtypes shared multiple MRE-
1270 sites with IFN-a1 AS, of which one to three
corresponding binding site sequences were identical or
very similar with those of either IFN-a1 AS/exon 1.1 DSR
or/exon 1.1, stop-SL2 listed in Supplementary Table 4 (see
Table 1). These MRE-1270 sites have been classified as the
six-nucleotide site matching the seed region [35].
The above results thus suggest that these specific sub-
types of IFN-a AS RNAs/mRNAs would be able to fulfill
the difference between the number of MRE-1270s in the
IFN-a1 AS and the number of miR-1270 molecules as
members of the interferon-a ceRNA network against the
miRNA.
Discussion
Similar to most cytokines, type I IFNs, namely IFN-a and
IFN-b, induce balanced responses in which activating
signals that induce antiviral states and promote immune
responses are counterbalanced by suppressive signals that
limit toxicity to the host and enable coexistence with
chronic pathogen infection. These balanced responses are
fine-tuned by host factors at multiple levels, including
signaling, transcriptional, post-transcriptional and transla-
tional levels to sculpt immune responses that are
appropriate for host defense and survival [36]. Aberrant or
excessive stimulation of any of these processes is believed
to underlie many inflammatory autoimmune disorders. For
example, RNA- and DNA-associated autoantigens in sys-
temic lupus erythematosus have been shown to drive
pathological expression of type I IFN genes and IFN-in-
duced genes through Toll-like receptor (TLR)7 and TLR9
activation [37]. The levels of type I IFNs, therefore, require
tight regulation to maintain a narrow window between
essential and pathological IFN expression.
We have previously demonstrated that IFN-a1 AS en-
hances the stability of IFN-a1 mRNA [11]. The data
presented here argue for an additional, synergistic role for
IFN-a1 AS in the post-transcriptional regulation of human
IFN-a1 mRNA stability. We present several lines of evi-
dence to show that IFN-a1 AS functions as a ceRNA to
prevent miR-1270 from acting on IFN-a1 mRNA. (1)
Overexpression of miR-1270 and transfection of antimiR-
1270 revealed that IFN-a1 AS is likely to share the miR-
1270 response elements (MRE-1270s) with IFN-a1
mRNA. Interactions between IFN-a1 AS and miR-1270
through the response elements would, therefore, titrate
away miR-1270 from IFN-a1 mRNA, suggesting that the
AS acts as an endogenous decoy or ceRNA for IFN-a1
mRNA. Indeed, antimiR-1270-dependent silencing of en-
dogenous miR-1270 caused de-repression of IFN-a1 AS
expression levels by 360 %, whereas the same treatment
raised IFN-a1 mRNA levels by 40 %, indicating that the
ceRNA functions as a decoy to protect the miRNA target.
Fig. 4 Effects of knockdown of endogenous miR-1270 function on
the expression levels of IFN-a AS RNAs and mRNAs. a, b The LNA-
modified antimiR-1270-transfected Namalwa cells used for the
analysis in Fig. 2b, c were analyzed for the expression levels of
IFN-a AS RNAs (a) and mRNAs (b) from the IFNA multigene
family. The relative expressions indicate the fold change of AS/
mRNA expression levels relative to those obtained from the LNA
mismatch control-transfected cells. *p\ 0.05, **p\ 0.01
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It has been reported that optimal ceRNA-mediated
cross-regulation occurs at a near-equimolar equilibrium
between all ceRNA-MREs and miRNAs within a network
[33]. However, all mammalian miRNA-competing RNAs
identified so far have only one or two binding sites for the
same miRNA and are not highly expressed, limiting their
potency [19, 21, 38–43]. (2) We, therefore, determined the
number of IFN-a1 AS segments that harbor the MRE.
Contrary to previous reports, the AS/exons 0.1 and 1.1
were found to host five segments with five MREs in total.
Since the copy number of IFN-a1 AS was estimated to be
1558 ± 82 per lg of total cellular RNA at 24 h after SeV
infection, the overall number of MRE-1270s in AS/exons
0.1 and 1.1 would account for approximately 30 % of the
miR-1270 population at the peak expression of the NAT
[11]. (3) To further fill the observed gap between the
number of ceRNA-MREs and the number of miR-1270
molecules, we examined the effects of antimiR-1270 on the
expression levels of AS RNAs and mRNAs from other
IFNA family subtypes, as well as on the expression levels
of other cellular mRNAs that share the MRE-1270.
The antimiR-1270 sequence is complementary to the
seed region of the mature miR-1270; therefore, in antimiR-
1270-transfected Namalwa cells, the abundance of miR
targets rises sufficiently to titrate out the miR-1270, re-
sulting in de-repression of all the targets of this miRNA
[41]. These titration effects can explain the antimiR-1270
overexpression results; specific de-repression of subtypes
of both IFN-a AS RNAs (IFN-a7, -a8, -a10 and -a14 AS
RNAs) as well as IFN- a mRNAs (IFN-a8, -a10, -a14 and
–a17 mRNAs). The transfection of antimiR-1270 also
caused specific de-repression of five other miR-1270 target
mRNAs, including that of CAPRIN1.
Recent studies have demonstrated that miRNA compe-
tition extends beyond the non-coding transcriptome and
potentially confers an additional non-protein-coding func-
tion to protein-coding mRNAs ([44]; [8] for a review);
therefore, in addition to the IFN-a1 AS, these IFN-a
mRNA subtypes and related antisense RNAs, as well as
specific cellular mRNAs, would also participate as com-
peting molecules in the IFN-a ceRNA network against
miR-1270.
The degree of specific de-repression of RNA expression
levels by antimiR-1270 exceeded that of IFN-a1 AS
(360 %) and mRNA (140 %) in IFN-a10 AS (430 %) as
well as all the IFN-a mRNA subtypes described above
(170–270 %). Furthermore, those de-repressed IFN-a AS
and mRNA subtypes were predicted to harbor one to three
6-mer type, MRE-1270 sites, whose sequences were
identical to or very similar to those in IFN-a1 AS. The
copy numbers of IFN-a mRNA subtypes that were de-re-
pressed exceeded the IFN-a1 mRNA copy number
throughout the time course examined in the SeV-infected
Namalwa cells [22]. Furthermore, silencing of endogenous
miR-1270 expanded the regulatory circuitry by the addition
of cellular mRNAs that share the MREs; therefore, the
results suggest that the overall numbers of MRE-1270s in
these molecules would be sufficient to fill the gap between
the number of MREs in the IFN-a1 AS and the number of
miR-1270 molecules, resulting in ceRNA network-medi-
ated cross-regulation of IFN-a1 mRNA levels (Fig. 5).
Very recently, mathematical models have indicated that
the affinity of miRNAs for their targets is another crucial
parameter for the establishment of ceRNA network-medi-
ated cross-regulation of gene expression. This especially
applies to miRNAs expressed at low levels, for which ef-
fective competition can only be performed by targets that
contain multiple MREs with high affinity [45] (see also
Fig. 3b). Apart from the total number of shared MRE-
1270s discussed above, this rule might also help to explain
the apparent paradox represented by IFN-a1 AS, which is
involved in a reciprocal ceRNA relationship with IFN-a1
mRNA [11] (see also Fig. 2a) despite the fact that it is
expressed at 15–25 times lower levels. As was suggested
Table 1 Number of predicted
MRE-1270s in subtypes of the
IFNA multigene family
Gene symbol MRE-1270s in IFN-α AS RNAs MRE-1270s in IFN-α mRNAs
Total 6-mer target sitesa Total 6-mer target sites
IFNA1 5 2 1 1
IFNA7 2 1 N.D.b N.D.
IFNA8 2 1 2 1
IFNA10 2 1 2 1
IFNA14 1 1 1 1
IFNA17 N.D. N.D. 4 3
aNumbers of 6-mer target sites matching the miR-1270 seed region classified by Bartel [35]are presented. A typical 6-mer MRE-
1270 target site on IFN-α1 AS is shown below. The box depicts the seed sequence of miR-1270 and the corresponding seed match 
on the AS RNA.         
Position:-121 - -101 (IFN-α1 AS/exon 1.1/DSR) 
5' A     C      AU        A 3'
AUAUA C CUUU    UCUCUA    
UGUGU G GAAG    AGAGGU    
MiR-1270   3'       C A    GUAU      C 5'
bN.D.: not experimentally confirmed by antimiR-1270 (see Fig. 4.)
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by Poliseno and Pandolfi [46], this exemplifies a com-
petitor that overcomes the limitation of being poorly
expressed by means of its high affinity for the IFN-a1
mRNA-targeting miR-1270.
Five mRNAs other than the IFN-a mRNA subtypes
were also shown to exert coding-independent function by
acting as ceRNAs to antagonize miR-1270. One of the
mRNAs, CAPRIN1, encodes an RNA-binding protein that
plays an essential role in the proliferation of immune cells,
including B lymphocytes, by the regulation of RNA
metabolism and translation [47]. CAPRIN1 can modulate
signaling events in the IFN response leading to transla-
tional activation [48], for example in the PI3K
(phosphatidylinositol-3 kinase)/Akt and Mnk (the mitogen-
activated protein kinase-integrating kinase 1) pathways that
are required for IFN-stimulated gene translation [49, 50]. It
is, therefore, interesting to note that the ceRNA-based
competition of miRNA activity may represent an addi-
tional, previously unidentified role for CAPRIN1 mRNA as
a modulator for antiviral immunity by fine-tuning the type I
IFN response.
This coordinated regulatory architecture suggests that it
is vital for the host innate immune system to maintain
precise type I IFN homeostasis via post-transcriptional
regulatory mechanisms. The above data, along with our
previous findings [11], indicate that the NAT-mRNA
regulatory network exerts control over the expression of
innate immunity by the proposed actions of IFN-a1 AS and
other important members of the IFN-a ceRNA network,
promoting target mRNA stability by transient duplex for-
mation and inhibiting miR-1270-induced mRNA decay.
These regulatory mechanisms play a pivotal role in deter-
mining the biological outcomes of type I IFN responses
and whether pathogens are cleared effectively or chronic
infection or autoimmune disease ensues.
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